Cartesian Therapeutics

Gaithersburg, United States

Pioneering Potent, Safer Cell Therapy in and Beyond Oncology

$50.0M raised

May 2026

Post-IPO Debt

Biotechnology Oncology

Top Investors

Invus K2 HealthVentures Surveyor Capital HBM Healthcare Investments Schooner Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cartesian Therapeutics

How much funding has Cartesian Therapeutics raised?

Cartesian Therapeutics has raised $50.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in May 2026.

Who are Cartesian Therapeutics's investors?

Cartesian Therapeutics's investors include Invus, K2 HealthVentures, Surveyor Capital, HBM Healthcare Investments, Schooner Capital.

Where is Cartesian Therapeutics headquartered?

Cartesian Therapeutics is headquartered in Gaithersburg, United States.

What does Cartesian Therapeutics do?

Pioneering Potent, Safer Cell Therapy in and Beyond Oncology

What stage is Cartesian Therapeutics at?

Cartesian Therapeutics is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 26, 2026.

MLA

"Cartesian Therapeutics — Funding & Investors." VCBacked, May 26, 2026, https://www.vcbacked.co/company/cartesian-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). Cartesian Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cartesian-therapeutics

Wikipedia (cite web)

{{cite web |title=Cartesian Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cartesian-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 26, 2026.